Skip to main content
. 2017 Oct 17;8(61):103919–103930. doi: 10.18632/oncotarget.21865

Figure 5. MiR-590-3P inhibits migration and invasion of HCC cells.

Figure 5

(A) Transwell migration analysis of HepG2 cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (B) Transwell migration analysis of MHCC97H cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (C) Transwell invasion analysis of HepG2 cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (D) Transwell invasion analysis of MHCC97H cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; *p<0.05, **p<0.01, and ***p<0.001.